NCT02801617 Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension Status TERMINATED Phase PHASE3
NCT02796560 Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT02792803 A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma Status UNKNOWN Phase PHASE4
NCT02743780 A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma Status COMPLETED Phase PHASE1/PHASE2
NCT02742649 A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT02730871 Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® Status TERMINATED Phase PHASE4
NCT02674854 Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02628223 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma Status COMPLETED Phase NA
NCT02623738 A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- Status COMPLETED Phase PHASE2/PHASE3
NCT02617459 Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02585375 Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT Status UNKNOWN Phase PHASE4
NCT02571712 Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT02558400 Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02558374 Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02537015 An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert Status COMPLETED Phase PHASE2
NCT02507687 Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT02471105 Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Status UNKNOWN Phase PHASE4